Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol
Conditions: COVID-19; SARS-CoV2 Infection Interventions: Biological: Ad5-triCoV/Mac; Biological: ChAd-triCoV/Mac Sponsors: McMaster University; Canadian Institutes of Health Research (CIHR) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials